Pharma Veterans

Corporate Values; Beyond Words – Asrar Qureshi’s Blog Post #1072 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1072 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Adriele Nenes Credit: Ketut Subiyanto Credit: Polina Zimmerman Preamble In one of the corporate that I was long associated with, a major decision was made during the annual strategy meeting of senior managers. A new gentleman had joined from an MNC, and he pointed out that this corporate did not have ‘corporate values’. He emphasized that without corporate values, the corporate was not good enough. It was decided in principal that corporate values shall be identified, adopted officially and promoted. The same gentleman also offered to share a booklet from his previous company which had a long list of corporate values which that company probably cla...

Thoughts on Flatter Corporate Hierarchy – Asrar Qureshi’s Blog Post #1037 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1037 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing our contributions here. Credit: Alena Darmel Credit: Cedric Fauntleroy Credit: Pavel Danilyuk Preamble In recent years, tech-based companies like Google, Meta, and Netflix are experimenting with doing away with the traditional hierarchical model and redistributing authority more evenly and horizontally. Bayer, the crop sciences giant and a well-known pharma company, last year went for radical decentralization. The jury is still out on how beneficial it is because more time is needed to analyze its pros and cons. This post is in continuation of previous discourse on the subject and invites open discussion. What Does It mean? Two models have been experimented with decentralizatio...

Status of Pharmaceutical Business in Pakistan 2024 – Part II – Asrar Qureshi’s Blog Post 962 Dear Colleagues! This is Asrar Qureshi’s Blog Post 962 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Kübra Kuzu Credit: Polina Tankilevitch Credit: Tran Nhu Tuan This is the second and last part. Corporates Growth Pakistan market is extremely unevenly divided with about 95% market share with only top 100 companies. The top players added further huge revenues to their already bursting volumes. They have also further strengthened their positions by increasing share of the total market. The top players have done this by growing at a rate higher than the market growth. How are they able to do it? There are several factors. Human Resource – The big players have the financial strength and market standing to attract top talent. Once a...

Corporate Management in Larger Organizations – Asrar Qureshi’s Blog Post #940 Dear Colleagues! This is Asrar Qureshi’s Blog Post #940 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Anete Lusina Credit: Brett Sayles Credit: Markus Winkler In this blog post, I shall present findings about corporate management or governance in larger organizations, be they private or public. Corporate management is the system of rules, practices, and processes through which a company is run, controlled, and directed. The culture of the organization evolves from governance, not the other way round. Corporate management, as mentioned earlier also, must balance the interests of all stakeholders. The shareholders should get return on their investment, suppliers look for on time payment of supplies, employees look for safe environment and caree...